Atara Biotherapeutics, Inc.Annual Report 2021

  • 2021

Income Statement

Million USD
Revenues
20.3
Cost of Revenues
Gross Profit
Research & Development
Selling, General & Administrative
78.8
Total Operating Expenses
360.8
Operating Income or Loss
-340.5
Interest (Expense) or Income
Other Income or (Expense)
-0.4
Earnings before Tax
-340.1
Income Tax
0.0
Net Income
-340.1
Net Income from Continued Operations
Net Income available to Common Shareholders

Balance Sheet

Million USD

Assets

Current Assets
Cash & Cash Equivalents
106.1
Short-term Investments
265.0
Net Receivables
1.0
Inventory
Other Current Assets
12.6
Total Current Assets
384.6
Non-Current Assets
Property, Plant & Equipment
Long-term Investments
Goodwill
Intangible Assets
Other Assets
Total Non-current Assets
83.5
Total
Total Assets
468.1

Liabilities & Equity

Current Liabilities
Accounts Payable
17.4
Short-term Debt
Other Current Liabilities
71.0
Total Current Liabilities
71.0
Non-current Liabilities
Long-term Debt
Other Liabilities
Total Non-Current Liabilities
188.5
Shareholders' Equity
Common Stock
0.0
Retained Earnings
-1,464.7
Accumulated Other Comprehensive Income (Loss)
1,744.7
Total Shareholders' Equity
279.6
Total
Total Liabilities & Shareholders' Equity
468.1

Cashflow Statement

Million USD
Operating Cashflow
Net Income
-340.1
Depreciation & Amortization
9.3
Receivables Changes
0.3
Liabilities Changes
Inventory Changes
Total Cashflow from Operating Activities
-220.5
Investing Cashflow
Investments
Capital Expenditures
10.6
Other Cashflows from Investing Activities
Total Cashflow from Investing Activities
Financing Cashflow
Dividend Payments
Sale/Purchase Of Stock
Net Borrowings
Other Cashflow from Financing Activities
6.5
Total Cashflow from Financing Activities
103.9
Total
Total Change in Cash & Equivalents
-94.3
Valuu.io

Valuu provides insights and tools for self-directed stock investors. It enables you to easily find, valuate and track your stock investments with the help of reliable financial data and transparent analysis tools.

Disclaimer: This website is a data portal, which aggregates information about public companies. It is not a stock broker and does not give advice concerning specific investment decisions or tax or legal advice. All data is provided "as-is" with no guarantee for correctness and/or completeness. All company names, logos, and brands are intellectual property of their respective owners. The use of them is for editorial purposes only and does not imply any affiliation or endorsement.
© 2022 Valuu Analytics Sàrl